Tura S, Carenza L, Baccarani M, Bagnara M, Bocci A, Bottone P, Bresadola M, Bruzzese G, Cassano F, Coccia M E
Recenti Prog Med. 1989 Nov;80(11):607-14.
A randomized polycentric study was programmed to establish the effects of daily administration of ferritin iron from early pregnancy to puerperium. 254 women with normal iron balance at the beginning of their pregnancy were randomized receiving no supplements or 40 mg iron daily. At the end of pregnancy iron balance was still normal only in one third of the pregnant women of the first group versus two third of the second group. 204 women who were iron-deficient received daily 40 or 120 mg of iron; in this group anemia developed less frequently (13% versus 29%) and iron balance normalized in one subject on four; the great majority of these women remained iron-deficient. Unwanted effects of minimal or mild relevance, and almost always sporadic were observed in 6.5% of cases and with the reduction or withdraw of the treatment in only 1.4% of cases. These results showed that daily administration of ferritin iron during pregnancy is effective and well tolerated; furthermore they suggest that the treatment must be done with at least 60 mg daily in women with normal iron balance and protracted also after the puerperium in iron deficient subjects.
一项随机多中心研究计划确定从妊娠早期至产褥期每日给予铁蛋白铁的效果。254名妊娠初期铁平衡正常的女性被随机分为两组,一组不补充铁剂,另一组每日补充40毫克铁。妊娠末期,第一组只有三分之一的孕妇铁平衡仍正常,而第二组为三分之二。204名缺铁女性每日接受40毫克或120毫克铁;该组贫血发生率较低(分别为13%和29%),四分之一的女性铁平衡恢复正常;这些女性中的绝大多数仍缺铁。6.5%的病例观察到极小或轻度相关的不良影响,且几乎均为偶发,仅1.4%的病例因减少或停用治疗出现不良反应。这些结果表明,孕期每日给予铁蛋白铁有效且耐受性良好;此外,研究表明,铁平衡正常的女性每日至少需补充60毫克铁,缺铁女性在产褥期后也需持续补充。